
In-Clinic Procedure
ARTHROSAMID® is injected into the knee joint space as an outpatient procedure. You do not need a hospital stay, and ultrasound guidance is used where appropriate.
A single-injection hydrogel treatment considered for suitable knee osteoarthritis after clinical assessment.
Arthrosamid® is an intra-articular polyacrylamide hydrogel (iPAAG) used for the symptomatic treatment of knee osteoarthritis in suitable patients. It is 97.5% water and 2.5% cross-linked polyacrylamide, delivered as a single injection into the knee joint space. Clinical follow-up has shown long-lasting symptom relief in selected patients, though response varies and suitability is decided at consultation.
From £2,400
Includes consultation, ultrasound-guided injection and aftercare. A single Arthrosamid treatment is designed to provide long-lasting relief in suitable patients.

Knee osteoarthritis affects the ordinary parts of life: stairs, shopping, walking, gardening, sleep and time with family. Many people manage well with exercise, weight management, medication or physiotherapy. Others reach a point where they want to discuss injection options before considering a surgical pathway.
Arthrosamid is not suitable for every painful knee. We assess your diagnosis, symptoms, examination findings, previous treatments, medical history and expectations before deciding whether it is the right option for you.

Once injected into the knee joint space, the Arthrosamid hydrogel becomes integrated with the soft tissues in the joint lining. The aim is to support symptom relief over the long term. It does not reverse arthritis, and results vary between patients.
We use ultrasound guidance where appropriate to visualise the knee joint and support accurate placement during the procedure. The injection is performed in clinic under local anaesthetic as an outpatient procedure — no hospital stay required.
Your consultation covers whether the pattern of pain, stiffness and function makes Arthrosamid a sensible choice compared with steroid injection, hyaluronic acid, PRF, physiotherapy or onward referral to orthopaedics.
Clinical follow-up shows that some patients report sustained improvements in pain and function for up to three to five years after a single injection. Suitability, individual response and duration of benefit vary, and are discussed honestly at consultation.

Arthrosamid is not appropriate for every painful knee, and we are direct about that at consultation. These are the three situations in which we most commonly discuss it as a considered option.
We explain each step before treatment so you know what to expect during the procedure, afterwards and if symptoms do not improve as hoped.

ARTHROSAMID® is injected into the knee joint space as an outpatient procedure. You do not need a hospital stay, and ultrasound guidance is used where appropriate.

You will have a consultation with the clinician to review your knee symptoms, medical history and suitability before any treatment is offered.

You receive aftercare advice before leaving clinic, including what to expect after the injection and when to contact us for review.
Download the official Arthrosamid patient brochure and the 3-year follow-up leaflet to learn more about how Arthrosamid may fit into your treatment plan.
Hear from a patient who chose Arthrosamid: a short testimonial about their experience of the treatment and their recovery.

We know it can feel difficult to book a procedure when you are not sure what will happen next.
Your clinician will explain suitability, risks, recovery and aftercare before treatment goes ahead.

Choose a consultation online or speak to the clinic if you are not sure which service fits. Most appointments are available within seven days.

An in-person review with Dr Mugerwa: he will listen to your story, examine the area and walk through what is going on.

An honest recommendation. If treatment is suitable we will explain the options, risks and likely outcomes. If it is not, we will tell you and refer you on.

The procedure itself, followed by tailored aftercare guidance and a clear contact route if anything changes during recovery.
“Dr Mugerwa was brilliant — made me feel at ease and kept me informed right through the procedure. Made my Arthrosamid injection pain free. Highly professional and would highly recommend. Thanks.”
Honest answers to the questions patients most often raise about Arthrosamid in clinic. If yours isn't covered here, ask at your consultation.
Clinical follow-up of patients with knee osteoarthritis has reported sustained reductions in pain and improvements in joint function over several years from a single Arthrosamid injection in suitable responders. Individual response varies, and not every patient achieves this duration of benefit. We discuss your specific likelihood of response — based on your imaging, examination and previous treatment — honestly at consultation.
Arthrosamid is considered for adults with moderate-to-severe knee osteoarthritis who have not had adequate relief from conservative options such as exercise, weight management, oral medication, physiotherapy, steroid injection or hyaluronic acid. It is not suitable for every painful knee. We assess your diagnosis, imaging, examination findings, previous treatments, medical history and expectations before deciding whether Arthrosamid is the right option.
For some patients, Arthrosamid can help delay or potentially avoid total knee replacement. For others, surgery will still be the appropriate path. Arthrosamid does not reverse arthritis or restore lost cartilage. What it offers selected patients is a non-surgical, single-injection option to consider before — or instead of — knee replacement. Your consultation will give you an honest picture of which route fits your situation.
Arthrosamid is a non-biodegradable hydrogel — the body does not metabolise or clear it. Over the weeks following injection, host synovial cells migrate into the gel matrix and it becomes integrated with the joint lining. It is not removed by routine activity, exercise or time. This is also why Arthrosamid is only offered after careful assessment — the decision needs to be a considered one.
Arthrosamid is given as a single outpatient injection under local anaesthetic, with ultrasound guidance used where appropriate to support accurate placement. The appointment typically lasts around 30 minutes. There is no hospital stay. Aftercare guidance is provided before you leave clinic, including what to expect over the following days and when to contact us.
The most commonly reported effects in the days after the injection are short-lived joint pain, swelling or stiffness. Joint infection is a recognised but uncommon risk of any joint injection, which is why we use strict sterile technique and assess for contraindications such as active skin infection. We discuss the specific risks relevant to your situation in detail at consultation so the decision is fully informed.
Arthrosamid is currently a privately-funded treatment in the UK. The Skin & Joint Injection Clinic is an independent, CQC-registered private clinic; you can refer yourself directly. The £2,400 fee includes consultation, the ultrasound-guided injection and aftercare. We're happy to discuss in advance whether Arthrosamid is likely to be a sensible investment for your particular knee.